3D Systems Corp. 10-Q Summary: Period Ended September 28, 2001
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 28, 2001, and the nine months ended on that date. 3D Systems Corporation develops, manufactures, and markets solid imaging systems (SLA, SLS, and ThermoJet) for rapid prototyping and manufacturing. The reporting period is significantly impacted by the August 2001 merger with DTM Corporation, as well as the acquisitions of OptoForm SARL and RPC Ltd. The company operates globally, with international revenues accounting for 53.8% of total revenue in the third quarter.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Sep 28, 2001 | 9 Months Ended Sep 28, 2001 | 9 Months Ended Sep 29, 2000 |
|---|---|---|---|
| Total Sales | $31,544 | $84,489 | $77,976 |
| Gross Profit | $13,519 | $37,634 | $37,564 |
| Gross Margin | 42.9% | 44.5% | 48.2% |
| Operating Income | $727 | $2,009 | $8,673 |
| Net Income | $231 | $1,252 | $5,759 |
| Diluted EPS | $0.02 | $0.10 | $0.45 |
| Cash & Equivalents (End of Period) | $8,528 (Sep 28, 2001) vs $18,999 (Dec 31, 2000) | ||
| Working Capital | $16,263 (Sep 28, 2001) vs $44,549 (Dec 31, 2000) | ||
| Total Debt Outstanding | $35.2 million ($20.2M Revolver + $15.0M Term Loan) |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 6.8% in Q3 and 8.4% for the nine-month period compared to the prior year. This growth is primarily driven by the consolidation of DTM Corporation, which contributed $7.3 million in revenue for the nine months.
- Profitability Decline: Despite revenue growth, Net Income dropped significantly (82% decrease for the nine months). Operating income fell from $8.7 million to $2.0 million. This was caused by a shift in product mix toward lower-margin smaller systems, increased operating expenses (SG&A and R&D) due to the DTM acquisition, and a general economic slowdown affecting high-end capital equipment sales.
- Product Mix Shift: Sales of high-end SLA 7000 systems decreased (7 units in Q3 2001 vs. 15 in Q3 2000). Conversely, sales of the new Viper Si2 system exceeded expectations (32 units in Q3 2001). SLS systems (from DTM) contributed $3.976 million in Q3 product sales.
- Liquidity and Debt: Cash and cash equivalents decreased by $10.5 million to $8.5 million, largely due to $48.6 million in cash used for the DTM acquisition. To finance this, the company replaced a $10M line of credit with a new $41.5M facility (U.S. Bank), resulting in $35.2 million in outstanding debt as of September 28, 2001.
Guidance, Outlook, and Risks
Management Commentary: Management expects the integration of DTM to be complete by the end of Q4 2001, at which time synergies and cost savings are anticipated. The company is focusing on multi-unit sales of SLA systems, cost controls, and expanding into rapid manufacturing and tooling markets. R&D expenses are expected to remain at 8% to 10% of sales.
Material Risks and Contingencies:
- Legal Litigation (EOS): EOS GmbH has filed a patent infringement suit against DTM (now 3D Systems) in California, claiming damages of approximately $27 million. EOS also threatened a breach of contract claim regarding competition in the laser sintering field. A trial date is set for July 8, 2003. International litigation with EOS in France, Germany, Italy, and Japan is ongoing.
- Supplier Termination (Vantico): The Distribution and R&D agreements with Vantico, Inc. (supplier of liquid photopolymers) are terminating in February 2002. This affects 18.3% of total revenues. The company has acquired RPC Ltd. to mitigate this risk, but disputes regarding confidential information and arbitration are pending.
- DOJ Divestiture: As part of the DTM merger settlement with the U.S. Department of Justice, 3D Systems must license either stereolithography or selective laser sintering technology to a third party by December 14, 2001.
- Economic Factors: The company cites a general economic slowdown and the impact of the September 11, 2001 events as factors affecting customer purchasing decisions and sales closures.
Investor Verification Checklist
- Debt Covenants: Verify the company's ability to meet interest coverage and EBITDA requirements under the new $41.5M U.S. Bank credit facility, given the decline in operating income.
- EOS Litigation Outcome: Monitor the status of the $27 million patent infringement claim and the potential for injunctions against SLS equipment sales.
- Vantico Transition: Assess the commercial viability and customer acceptance of RPC resins as a replacement for Vantico photopolymers following the February 2002 contract termination.
- DOJ Compliance: Confirm the successful execution of the required patent licensing divestiture by the December 14, 2001 deadline.
- Product Mix Margins: Analyze future quarters to determine if the shift from high-end SLA systems to smaller systems and SLS equipment will permanently alter gross margin structures.